Clinical Trials in Lørenskog, Akershus
17 recruiting
Showing 1–17 of 17 trials
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Merck Sharp & Dohme LLC780 enrolled260 locationsNCT06312137
Recruiting
Not Applicable
Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
Oncosyne AS75 enrolled1 locationNCT07171554
Recruiting
Phase 3
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Merck Sharp & Dohme LLC1,200 enrolled196 locationsNCT06136559
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled274 locationsNCT06152575
Recruiting
Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled229 locationsNCT06077760
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled268 locationsNCT06966700
Recruiting
Phase 2Phase 3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Bristol-Myers Squibb470 enrolled160 locationsNCT07106762
Recruiting
Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC1,310 enrolled282 locationsNCT06136624
Recruiting
Phase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
AbbVie540 enrolled254 locationsNCT06548542
Recruiting
Not Applicable
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
OncologyCardiovascular DiseasesRare Diseases+3 more
Technical University of Madrid3,100 enrolled10 locationsNCT06856902
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Not Applicable
Akershus Cardiac Examination (ACE) 5 Study
Lung Cancer ScreeningHeavy SmokersCardiovascular Risk Profile+1 more
University Hospital, Akershus1,000 enrolled1 locationNCT07301489
Recruiting
Not Applicable
Management of Patients with Heart Failure At Home After Hospital Discharge
Heart Failure
University Hospital, Akershus450 enrolled2 locationsNCT06576752
Recruiting
Not Applicable
How to Best Treat Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Injuries
University Hospital, Akershus328 enrolled2 locationsNCT04770233
Recruiting
Tailoring Treatment in Colorectal Cancer
Colorectal Neoplasms
University Hospital, Akershus40 enrolled1 locationNCT05401318
Recruiting
Not Applicable
A Study to Improve the Collaboration Between Primary and Secondary Health Care on the Treatment of Osteoporosis After a Hip Fracture.
OsteoporosisHip FracturesZoledronic Acid+2 more
University Hospital, Akershus200 enrolled1 locationNCT05904353
Recruiting
Phase 2
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Breast CancerHeart FailureMetastatic Breast Cancer+2 more
University Hospital, Akershus60 enrolled1 locationNCT05732051